
CAS 923270-50-2
:Cyclopenta[c]pyrrole-1-carboxamide, (2S)-2-cyclohexyl-N-(2-pyrazinylcarbonyl)glycyl-3-méthyl-L-valyl-N-[(1R)-1-[2-(cyclopropylamino)-2-oxoacétyl]butyl]octahydro-, (1S,3aR,6aS)-
- Telaprevir (R)-Isomer
- Cyclopenta[c]pyrrole-1-carboxaMide, (2S)-2-cyclohexyl-N-(2-pyrazinylcarbonyl)glycyl-3-Methyl-L-valyl-N-[(1R)-1-[2-(cyclopropylaMino)-2-oxoacetyl]butyl]octahydro-, (1S,3aR,6aS)-
- (R)-Telaprevir
- (1S,3aR,6aS)-(2S)-2-Cyclohexyl-N-(2-pyrazinylcarbonyl)glycyl-3-methyl-L-valyl-N-[(1R)-1-[2-(cyclopropylamino)-2-oxoacetyl]butyl]octahydrocyclopenta[c]pyrrole-1-carboxamide
Cyclopenta[c]pyrrole-1-carboxaMide, (2S)-2-cyclohexyl-N-(2-pyrazinylcarbonyl)glycyl-3-Methyl-L-valyl-N-[(1R)-1-[2-(cyclopropylaMino)-2-oxoacetyl]butyl]octahydro-, (1S,3aR,6aS)-
CAS :Formule :C36H53N7O6Degré de pureté :97%Masse moléculaire :679.8493(R)-Telaprevir-d4
CAS :Produit contrôléApplications (R)-Telaprevir-d4 is the labeled analog of (R)-Telaprevir, an enantiomer of Telaprevir (T015650). Telaprevir is an known inhibitor of the hepatitis C virus NS3-4A protease. It is a COVID19-related research product.
References Francois, J., et al.: J. Medn. Chem., 52. 7993 (2009); Kieffer, T., et al.: Hepatology, 46, 631 (2007), Zhou, Y., et al.: Antimicrob. Agents Chemother., 52, 110 (2008), Hezode, C., et al.: N. Engl. J. Med., 360, 1839 (2009);Formule :C36H49D4N7O6Couleur et forme :NeatMasse moléculaire :683.87(R)-Telaprevir
CAS :Produit contrôléApplications (R)-Telaprevir is an enantiomer of Telaprevir (T015650), an inhibitor of the hepatitis C virus NS3-4A protease. It is a COVID19-related research product.
References Francois, J., et al.: J. Medn. Chem., 52. 7993 (2009); Kieffer, T., et al.: Hepatology, 46, 631 (2007), Zhou, Y., et al.: Antimicrob. Agents Chemother., 52, 110 (2008), Hezode, C., et al.: N. Engl. J. Med., 360, 1839 (2009);Formule :C36H53N7O6Couleur et forme :NeatMasse moléculaire :679.85(R)-Telaprevir
CAS :Telaprevir is a small molecule that binds to the cytoplasmic domain of the human immunodeficiency virus type 1 (HIV-1) envelope protein, blocking its fusion with host cells. Telaprevir is also an inhibitor of hepatitis C virus (HCV) NS3 protease. The binding of telaprevir to HIV-1 and HCV is selective and reversible. This drug has been shown to be effective in inhibiting the replication of HIV-1 and HCV in vitro, as well as in clinical trials. Telaprevir binds to the active site of the protease, preventing cleavage of a polyprotein into three parts: p7, p2, and p6. Telaprevir is an ion channel blocker that inhibits potassium channels. It can be used as a research tool for studying ligand-receptor interactions or protein interactions with peptides. Telaprevir is a high purity product with CAS No.Formule :C36H53N7O6Degré de pureté :Min. 95%Masse moléculaire :679.8 g/mol



